Asset management
  • Competitive risk-return performance
  • Advanced proactive strategy based on regression models
  • Broad exposure to biotechnology and pharmaceutical sectors
  • Transparent and secure infrastructure
Capital markets
  • Full organization of bond issues in Europe and the USA
  • Equity capital markets (M&A, SPAC, exit)
  • Legal expertise (documents on transactions, issues) and engineering
  • Investor relations / Government relations

Our partners


Terms of use

We process information about your visit using cookies in order to improve our website.
By continuing to browse, you agree to our privacy policy.

Agree Terms of Use